In this video, A/Prof. Andrew Weickhardt leads a case-based discussion on cisplatin eligibility in metastatic urothelial carcinoma.
A/Prof. Andrew Weickhardt is Medical Oncologist and Translational Researcher at the Olivia Newton John Cancer and Wellness Centre, Austin Health, Melbourne.
(17 minutes)
This video is part of a series exploring the management of metastatic urothelial cancer.
Other videos in the series include:
- An update on first-line treatment approaches by Carole Harris
- Subsequent lines of therapy post-chemotherapy and maintenance therapy by Ben Tran
- Long-term survivorship considerations by Diana Adams
These videos were created independently by the limbic. All case studies were developed by the presenters and views are those of the presenters alone.
Thank you to the Merck Pfizer Alliance for providing a non-restrictive educational grant that made this project possible.
